Biote Revenue Growth Rates (BTMD), Current and Historic Growth - CSIMarket
CSIMarket
 


Biote Corp   (NASDAQ: BTMD)
 

BTMD's Revenue Growth by Quarter and Year

Biote 's Revenue results by quarter and year




BTMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 44.23
1st Quarter March 44.94
FY 89.17





BTMD Revenue second quarter 2026 Y/Y Growth Comment
Biote Corp reported decrease in Revenue in the second quarter 2026 by -9.47% to $ 44.23 millions, from the same quarter in 2025.
The decrease in the second quarter 2026 Biote Corp 's Revenue compares unfavorably to the Company's average Revenue growth of 6.2%.

Looking into second quarter 2026 results within Legal Cannabis industry 17 other companies have achieved higher Revenue growth. While Biote Corp ' s Revenue decline of -9.47% ranks overall at the positon no. 3311 in the second quarter 2026.




BTMD Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - -6.86 % 9.04 % 2.72 %
3rd Quarter September - -6.66 % 12.77 % 8.55 %
2nd Quarter June -9.47 % -0.63 % -0.18 % 19.1 %
1st Quarter March -8.27 % 4.68 % 4.37 % 20.73 %
FY   - -2.52 % 6.38 % -

Financial Statements
Biote 's second quarter 2026 Revenue $ 44.23 millions BTMD's Income Statement
Biote 's second quarter 2025 Revenue $ 48.86 millions Quarterly BTMD's Income Statement


BTMD Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - -3.23 % -3.02 % 0.31 %
3rd Quarter September - -1.84 % 4.49 % -7.51 %
2nd Quarter June -1.58 % -0.27 % 5.06 % 9.86 %
1st Quarter March -3.17 % -1.69 % 2.41 % 0.79 %
FY (Year on Year)   - -2.52 % 6.38 % -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #18
Consumer Non Cyclical Sector #133
Overall #3311

Revenue Y/Y Growth Statistics
High Average Low
20.73 % 6.2 % -9.48 %
(Mar 31 2025)   (Jun 30 2026)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #18
Consumer Non Cyclical Sector #133
Overall #3311
Revenue Y/Y Growth Statistics
High Average Low
20.73 % 6.2 % -9.48 %
(Mar 31 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Biote 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
11.35 % 1.31 % -7.51 %
(Jun 30 2022)  


BTMD's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Biote Corp disclosed decrease in Revenue from the first quarter by -1.58% to $ 44.23 millions, from $ 44.94 millions achived in the previous reporting period.

But that's not important problem, as Biote 's Revenue generally seem to plunge in this quarter.

Within Legal Cannabis industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Biote 's Revenue growth quarter on quarter, overall rank is 2053.


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #5
Consumer Non Cyclical Sector #64
Overall #2053
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #5
Consumer Non Cyclical Sector #64
Overall #2053
Revenue Q/Q Growth Statistics
High Average Low
11.35 % 1.31 % -7.51 %
(Jun 30 2022)  


BTMD's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Biote Corp disclosed decrease in Revenue from the first quarter by -1.58% to $ 44.23 millions, from $ 44.94 millions achived in the previous reporting period.

But that's not important problem, as Biote 's Revenue generally seem to plunge in this quarter.

Within Legal Cannabis industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Biote 's Revenue growth quarter on quarter, overall rank is 2053.


Biote 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 183.53 $ 188.16 $ 192.22 $ 195.65 $ 199.07
Y / Y Revenue Growth (TTM) -7.81 % -5.63 % -2.52 % 1.34 % 6.32 %
Year on Year Revenue Growth Overall Ranking # 1350 # 2187 # 2593 # 2671 # 2070
Seqeuential Revenue Change (TTM) -2.46 % -2.11 % -1.75 % -1.72 % -0.15 %
Seq. Revenue Growth (TTM) Overall Ranking # 2475 # 2397 # 2026 # 1839 # 1813


Cumulative Revenue growth Comment
Biote 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.81% year on year, at Jun 30 2026 compare to the -5.63% decrease at Mar 31 2026. If the Biote 's fiscal year would end at Jun 30 2026, annual Revenue would be $184 millions.

In the Consumer Non Cyclical sector 43 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1350, from total ranking in previous quarter at 2187.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 12
Consumer Non Cyclical Sector # 44
Overall # 1350

Revenue TTM Y/Y Growth Statistics
High Average Low
10.55 %
-0.2 %
-9.77 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 90
S&P 500 # 2475
Cumulative Revenue growth Comment
Biote 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.81% year on year, at Jun 30 2026 compare to the -5.63% decrease at Mar 31 2026. If the Biote 's fiscal year would end at Jun 30 2026, annual Revenue would be $184 millions.

In the Consumer Non Cyclical sector 43 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1350, from total ranking in previous quarter at 2187.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 12
Consumer Non Cyclical Sector # 44
Overall # 1350

Revenue TTM Y/Y Growth Statistics
High Average Low
10.55 %
-0.2 %
-9.77 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 90
S&P 500 # 2475




Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BTMD's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Jun 30 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Tyson Foods Inc -0.12%$ -0.115 millions
Tootsie Roll Industries Inc-0.17%$ -0.171 millions
Ascend Wellness Holdings, Inc.-0.93%$ -0.932 millions
Andersons Inc -1.22%$ -1.218 millions
Scotts Miracle gro Co-1.34%$ -1.338 millions
Kraft Heinz Co-1.42%$ -1.417 millions
Willamette Valley Vineyards Inc -1.56%$ -1.564 millions
Post Holdings Inc -1.83%$ -1.829 millions
The Marzetti Company-2.19%$ -2.187 millions
Smithfield Foods Inc -2.30%$ -2.297 millions
Pilgrim s Pride Corporation-2.76%$ -2.755 millions
The Boston Beer Company Inc -3.34%$ -3.335 millions
Niagen Bioscience Inc -4.28%$ -4.281 millions
Mosaic Co-6.04%$ -6.042 millions
J and j Snack Foods Corp -6.19%$ -6.186 millions
Beyond Meat Inc -7.72%$ -7.721 millions
Central Garden and Pet Company-8.09%$ -8.088 millions
Golden Growers Cooperative-8.38%$ -8.378 millions
American Vanguard Corporation-9.17%$ -9.174 millions
Biote Corp -9.48%$ -9.478 millions
Vital Farms Inc -9.66%$ -9.660 millions
Trulieve Cannabis Corp.-10.31%$ -10.306 millions
Reed s Inc -14.98%$ -14.977 millions
Longevity Health Holdings Inc -21.37%$ -21.370 millions
Solesence Inc -22.87%$ -22.866 millions
Upexi Inc -26.57%$ -26.574 millions
Medifast Inc -27.01%$ -27.006 millions
The Hain Celestial Group Inc -27.60%$ -27.599 millions
22nd Century Group inc -29.86%$ -29.855 millions
Hydrofarm Holdings Group Inc -40.17%$ -40.169 millions


About Biote Revenue Growth Rates (BTMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Biote Corp (CIK 1819253).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-340364
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Biote Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.